The purpose of this study was to evaluate the diagnostic accuracy of coronary artery occlusion (CAO) and myocardial perfusion defect (MPD) identified on non-gated enhanced chest CT in patients with acute myocardial infarction (AMI). We retrospectively assessed 99 patients with AMI (group 1, = 33) and without AMI (group 2, = 66) who underwent non-gated chest CT. We analyzed the presence of MPD and CAO on non-gated chest CT. MPD on the CT was categorized using a three-point scale (0 = no definite MPD; 1 = probable artifact or questionable MPD; 2 = probable MPD). Presence of CAO was defined as an abrupt change of contrast enhancement in a coronary artery segment with no or minimal coronary motion on the CT. There were 42.4% and 12.1% patients with probable MPD ( = 0.002), and 18.2% and 0% patients with CAO ( = 0.001) in groups 1 and 2, respectively. Probable MPD alone and simultaneous presence of CAO and probable MPD to predict AMI resulted in sensitivity, specificity, negative predictive value, and positive predictive valve of 42.4%, 87.9%, 75.3%, and 63.6%, respectively, and 12.1%, 100%, 69.5%, and 100%, respectively. In conclusion, probable MPD alone on non-gated chest CT demonstrated a relatively low sensitivity, high specificity, and modest positive predictive value for the prediction of AMI on non-gated enhanced chest CT. Although it is rare, simultaneous presence of CAO and probable MPD had a high positive predictive value to predict AMI on non-gated enhanced chest CT.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544712 | PMC |
| http://dx.doi.org/10.3390/tomography7040043 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association Between Serum Ustekinumab Concentrations and Endoscopic Disease Activity in Moderate-to-Severe Crohn's Disease Patients.
Crohns Colitis 360
October 2024
Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, QC, Canada.
Background/aims: The role of ustekinumab therapeutic drug monitoring in patients with Crohn's disease (CD) remains ambiguous. Examination of the association serum ustekinumab concentrations and endoscopic outcomes has yielded inconsistent results. Our study examined whether serum ustekinumab concentrations were associated with endoscopic healing in patients with moderate-to-severe CD.
View Article and Find Full Text PDFAppropriate linear stapler selection for avoiding postoperative pancreatic fistula after distal pancreatectomy: A retrospective cohort study.
Medicine (Baltimore)
October 2024
Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Background: Despite the progress in surgical techniques and perioperative managements, the incidence of postoperative pancreatic fistula (POPF) after distal pancreatectomy (DP) remains high. Recently, pancreatic dissection using a linear stapler has been widely performed; however, risk factors influencing the occurrence of POPF after DP using a liner stapler is not fully understood. The purpose of this paper was to evaluate whether the relations between staple height and pancreatic thickness or main pancreatic duct (MPD) diameter influenced the incidence of POPF.
View Article and Find Full Text PDFPreoperative prognostic stratification and prediction of long-term outcomes after pancreatoduodenectomy for distal cholangiocarcinoma.
Eur J Surg Oncol
December 2024
Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Yamane, Hidaka-City, Saitama-Pref, Japan.
Article Synopsis
- Patients with distal cholangiocarcinoma (DCC) often receive chemotherapy, but predicting their survival risk during treatment selection is difficult.
- This study analyzed 170 DCC patients who underwent pancreatoduodenectomy between 2009 and 2022, using various clinical parameters to identify overall survival (OS) risk factors through Cox regression analysis.
- Key findings showed that tumor size ≥15 mm and main pancreatic duct dilatation (≥3 mm) significantly impacted OS; patients with two risk factors had a poor 5-year OS of only 8%, suggesting that more aggressive treatment options should be considered for these individuals.
Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study.
EClinicalMedicine
October 2024
Division of Cardiology, Department of Pediatrics, Oregon Health and Science University-Doernbecher Children's Hospital, Portland, OR, USA.
Article Synopsis
- The study investigated the clinical features and long-term outcomes of myocarditis linked to COVID-19 vaccination, focusing on 333 affected patients under 30 compared to 100 with MIS-C.
- Findings indicated that C-VAM patients were mostly young white males, experienced milder symptoms initially, but had higher rates of myocardial injury as shown by cardiac imaging.
- Despite a generally benign course and no reported cardiac deaths during follow-up, 60% of patients still showed evidence of myocardial injury after approximately six months.
Main pancreatic duct involved IPMN without high-risk factors: how to judge the degree of malignancy based on MPD dilation?
Medicine (Baltimore)
August 2024
Department of Radiology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.
Article Synopsis
- * Researchers analyzed data from 142 patients with either main pancreatic duct (MPD)-involved or branch-duct intraductal papillary mucinous neoplasms (IPMNs) and used statistical methods to identify malignant risk factors.
- * They found that an MPD diameter greater than 7.5 mm and elevated levels of a specific tumor marker (Ca19-9) were significant predictors of malignant IPMNs, with their combined use improving diagnostic accuracy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!